Genprex

Tagged: Type 1 Diabetes

Genprex Announces Groundbreaking Data from Non-Human Primate Study Evaluating Novel Gene Therapy to Treat Type 1 Diabetes at 16th Annual International Conference on Advanced Technologies & Treatment for Diabetes 2023

Results show statistically significant decreases in insulin requirements, increases in c-peptide levels and improvements in glucose tolerance compared to baseline

Read More

Genprex Strengthens Diabetes Gene Therapy Program with License of Additional Technology from University of Pittsburgh

Technology for modulating autoimmunity expands intellectual property portfolio

Read More